Molecular Markers of Chemosensitivity for Bladder Cancer

A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion

NCT04255771 ·Status: UNKNOWN ·Phase: PHASE3

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

NCT02716961 ·Status: UNKNOWN ·Phase: NA

Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer

NCT05822934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy

NCT04966975 ·Status: UNKNOWN

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

NCT07261592 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Basal Tumours in Bladder Cancer, Response to chemoTherapy

NCT04089748 ·Status: COMPLETED

Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer

NCT01801644 ·Status: COMPLETED ·Phase: NA

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

NCT03324282 ·Status: TERMINATED ·Phase: PHASE2

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

NCT06257017 ·Status: RECRUITING ·Phase: PHASE2

Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

NCT05767528 ·Status: UNKNOWN

Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer

NCT04245618 ·Status: UNKNOWN

Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

NCT07225374 ·Status: RECRUITING ·Phase: PHASE2

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

NCT02861196 ·Status: COMPLETED ·Phase: NA

Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics

NCT04966962 ·Status: UNKNOWN

Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer

NCT01734798 ·Status: COMPLETED ·Phase: PHASE3

Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer

NCT05203913 ·Status: RECRUITING ·Phase: PHASE2

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

NCT00491114 ·Status: COMPLETED ·Phase: PHASE2

CD155 in Bladder Cancer

NCT03789682 ·Status: COMPLETED

Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma

NCT04570410 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC

NCT02876861 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

NCT04909775 ·Status: UNKNOWN ·Phase: PHASE2

Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer

NCT06916494 ·Status: RECRUITING ·Phase: PHASE1

Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma

NCT04812145 ·Status: UNKNOWN

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

NCT03413982 ·Status: RECRUITING

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

NCT01050504 ·Status: RECRUITING